1-tetrahydropyranylcarbonyl-2,3-dihydro-1H-indole compounds for treating cancer
The present invention relates to certain novel 2,3-dihydro-1H-indole compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, more particularly for the treatment of cancer selected from the group consisting of melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal cancer, breast cancer, lung cancer, ovarian cancer, fallopian tube carcinoma, primary peritoneal carcinoma, cervical cancer, gastric cancer, liver cancer, pancreatic cancer, thyroid cancer, glioblastoma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma.
Eli Lilly and Company
C A C C C C A
C07D A61P C07C C07D C07D C07C A61K
inventional inventional inventional inventional additional additional inventional
James Robert Bradley Earl William Thomas Jolie Anne Almudena Jiehao Jeffrey Daniel Gaiying Daniel Jon
Henry Reaman McMillen Bastian Rubio Chen Cohen Zhao Sall